Perimenopausal Women Face Greater Heart Risk, Study Finds
Medically reviewed by Drugs.com
via HealthDayWEDNESDAY, May 13, 2026 — Women entering menopause are twice as likely to have lower heart health scores than those still having regular periods, a new study says.
Perimenopausal women are more likely to have high cholesterol and blood sugar levels, researchers reported today in the Journal of the American Heart Association.
These problems likely are fueled by varying estrogen levels, which can negatively affect cholesterol, insulin resistance, blood pressure and weight, researchers said.
But diet also plays a powerful role, with women’s healthy nutrition scores declining as they begin and then enter menopause, the study found.
“Mid-life women should think of the perimenopausal period as a ‘window of opportunity.’ They should be proactive and not wait until they reach menopause to start checking their blood pressure, cholesterol and blood sugar levels,” said senior researcher Dr. Garima Arora, an professor of medicine at the University of Alabama at Birmingham.
“Women should talk with their health care team about their reproductive status and any changes they are experiencing,” Arora said in a news release. “It may be the perfect time to get a baseline for their heart health.”
For the new study, researchers assessed more than 9,200 women’s heart health using the American Heart Association’s Life’s Essential 8, which tracks tracks lifestyle factors (diet, physical activity, tobacco use and sleep) and health metrics (blood pressure, cholesterol levels, body weight and blood sugar levels).
The women, ages 18 to 80, participated in a federal health and nutrition survey between 2007 and 2020.
The team looked specifically at perimenopause, the time at which women’s hormone levels start to fluctuate and their menstrual cycles become irregular. A woman is considered past menopause when 12 consecutive months pass after her final period.
Results showed that women’s LE8 scores declined steadily, from 73 out of 100 in premenopausal women to 69 in perimenopausal women and 64 for women post-menopause.
Women undergoing menopause were twice as likely to have an overall low heart health score than those who hadn’t yet started menopause, even after researchers accounted for the effect of aging.
They also were 76% more likely to have higher cholesterol and 83% more likely to be struggling to control elevated blood sugar, the study found.
“Our analysis highlights that perimenopause, women’s reproductive transition period to menopause, is the critical time when the increase in cardiovascular risk seems magnified,” lead researcher Dr. Amrita Nayak said in a news release. Nayak is a research fellow in cardiovascular disease at the University of Alabama at Birmingham.
Diet consistently received the lowest score across all eight heart health factors, researchers noted.
“Nutrition can be a central factor for early and proactive intervention,” Arora said. “Focusing on heart-healthy habits early, especially getting regular exercise and following a healthy eating plan like the DASH diet with a focus on lowering salt can help improve cardiovascular health for perimenopausal women in the years to come.”
Researchers next plan to follow a group of women over several years to track their hormone levels and heart health, researchers said.
“I encourage women to talk with their primary care and specialty health care teams to learn about early detection and modification of traditional and ‘female-specific’ risk factors,” Dr. Stacey Rosen, volunteer president of the American Heart Association, said in a news release.
“Women can take proven steps to improve their cardiovascular health at all ages,” added Rosen, who reviewed the findings.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-05-13 21:24
Read more
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Nearly Half of Women Misunderstand Breast Cancer Screening Guidelines
- Removing Universal Hep B Shot Likely to Increase Neonatal Infections
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- FDA Approves Bizengri for Rare Bile Duct Cancer
- Most Calcitonin Gene-Related Peptide Targeted Therapies Effective for Migraine Prophylaxis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions